|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 134 | NFAT Is a Determining Factor in Preferential HIV-1 Replication of CD45RO-Expressing CD4+ T Cells
G. A. Robichaud*1, B. Barbeau1, J.-F. Fortin1, D. M. Rothstein2, and M. J. Tremblay1 1Univ. Laval, Québec, PQ, Canada and 2Yale Univ., New Haven, CT, USA |
| 135 | Presentation of HIV gp120 Antigen to CD4 T-Helper Cells Is Prevented by Antibodies
P. Chien, Jr.1, M. Tuen1, P. D. Chen1, S. Cohen1, C. Kleeberger2, J. Giorgi3, J. Phair4, S. Zolla-Pazner1, and C. E. Hioe*1 1New York Univ. and VA Med Ctrs, NY, USA; 2Johns Hopkins Sch. of Publ. Hlth., Baltimore, MD, USA; 3UCLA Med. Sch., Los Angeles, CA, USA; and 4Northwestern Med. Sch., Chicago, IL, USA |
| 136 | Why Antigen-Specific CD8 T Lymphocytes Fail to Prevent Progressive Immunodeficiency in HIV-1 Infection
J. Andersson1, K. Lore1, A. Sonnerborg1, L. Perrin2, D. Cooper3, B. Gazzard4,S. Kinloch4, R. Weber5, H. Stellbrink6, C. Tsoukas7, G. Tambussi8, and L. Goh9 Depts. of Inf. Diseases, 1Sweden, 2Geneva, 3Australia, 4London, 5Zurich, 6Hamburg, 7Montreal, 8Milan, and 9GlaxoSmithKline |
| 137 | In Vivo Expression of Cytokines and Chemokines and HIV-1 Disease Progression: Role of HTLV-II Coinfection
E. Vicenzi*1, C. Casoli2, S. Ghezzi1, U. Bertazzoni3, and G. Poli1 1San Raffaele Scientific Inst., Milan, Italy; 2Univ. of Parma, Italy; and 3Univ. of Verona, Italy |
| 138 | Evolution of Promoter Activities of Attenuated Strains of HIV-1
M. J. Churchill*, I. de Castella, D. Rhodes, D. McPhee, and N. Deacon Macfarlane Burnet Ctr. for Med. Res., Fairfield, Victoria, Australia |
| 139 | First Evidence Showing Absence of in Vivo Evolution in HIV-1 over Time: Implications for HIV Vaccine Development
B. Wang*, M. Mikhail, and N. K. Saksena CVR, Westmead Millennium Inst., Westmead Hosp., Univ. of Sydney, Sydney, NSW, Australia |
| 140 | Predictors of Disease Progression in LTNP: A 5-Year Follow-Up Study
E. Vicenzi1, S. Ghezzi1, G. Vallanti1, F. Neri1, D. Douek2, E. Santagostino3, A. Gringeri3, M. Cusini3, A. Lazzarin1, F. Veglia4, and G. Poli*1 1San Raffaele Scientific Inst., Milano, Italy; 2Vaccine Res. Ctr., NIH, Bethesda, MD, USA; and 3IRCCS Maggiore Hosp., Milano, Italy |
| 141 | Immune Correlates of HIV-1 Disease Progression in Subtype E-Infected Thais
T. Chuenchitra*1, C. Wasi2, S. Louisirirotchanakul2, M. de Souza1, S. Nitayaphan1, R. Sutthent2, A. Brown1, D. Birx3, and V. Polonis3 1AFRIMS, Bangkok, Thailand; 2Siriraj Hosp. Bangkok, Thailand; and 3US Military HIV Res. Program, Rockville, MD, USA |
| 142 | Plasma SDF-1 Levels, SDF1-3 A. Soriano*1, C. Martinez1, E. Palou1, F. García1, M. Plana1, J. M. Aróstegui1, M. Lejeune1, J. del Romero2, C. Rodriguez2, A. Barrasa2, J. I. Lorenzo3 , J. M. Miró1, J. M. Gatell1, and T. Gallart1 1Hosp. Clin., Barcelona, Spain; 2Centro Médico Sandoval, Madrid, Spain; and 3Hosp. La Fe, Valencia, Spain |